33620 Results

People

  1. Ladanyi
    Ladanyi
  2. Giralt
    Giralt
  3. Motzer
    Motzer
  4. Reuter
    Reuter
  5. Perales
    Perales
  6. Scher
    Scher
  7. Zelenetz
    Zelenetz
  8. Berger
    Berger
  9. Al-Ahmadie
    Al-Ahmadie
  10. O'Reilly
    O'Reilly

Groups

  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)
  7. Department of Pathology and Laboratory Medicine (5172)
  8. Surgery (4871)
  9. Sloan Kettering Institute Faculty (3826)
  10. Sloan Kettering Institute Postdocs (3612)
  1. "Meeting abstract"
Formats
  1. Meeting Abstract (33620)
Groups
  1. Department of Medicine (15822)
  2. Solid Tumor Oncology Division (9435)
  3. GSK Faculty (7076)
  4. Hematologic Malignancies, Division of (6210)
  5. Center for Hematologic Malignancies (6017)
  6. Survivorship Research (5192)

More Groups

People
  1. Marc Ladanyi (641)
  2. Sergio Giralt (632)
  3. Robert Motzer (574)
  4. Victor Reuter (568)
  5. Miguel-Angel Perales (482)
  6. Howard Scher (463)

More People

Years
  1. 2025 (295)
  2. 2024 (1694)
  3. 2023 (1954)
  4. 2022 (2196)
  5. 2021 (1731)
  6. 2020 (1901)

More Years

Publications
  1. Journal of Clinical Oncology (6252)
  2. Blood (3939)
  3. Laboratory Investigation (1846)
  4. Cancer Research (1822)
  5. International Journal of Radiation Oncology, Biology, Physics (1643)
  6. Modern Pathology (1494)

More Publications

Publishers
  1. American Society of Clinical Oncology (6251)
  2. Elsevier Inc. (4694)
  3. American Society of Hematology (3939)
  4. American Association for Cancer Research (3045)
  5. Nature Publishing Group (2151)
  6. Oxford University Press (2096)

More Publishers

Results (33620)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BIO25-027: Addressing early diagnosis challenges: Utilizing C the Signs clinical decision support platform for pancreatic cancer risk assessment
    Meeting Abstract

    Raoof, S.; Dadhania, S.; Patel, T.; Herrick, B.; Bakshi, B.; Payling, M.
    Journal of the National Comprehensive Cancer Network (2025)

    Fulltext@MSK | Save
  • TIP25-244: Comprehensive Outcomes for After Cancer Health (COACH) Study: 2024 trial in progress updates
    Meeting Abstract

    Brassil, K.; Halpenny, B.; Arthur, E.; Swartz, M. C.; Kaler, A.; Krok-Schoen, J.; Lally, R.; Loftis, J.; Saligan, L.; Schmidt, R.; more...
    Journal of the National Comprehensive Cancer Network (2025)

    Fulltext@MSK | Save
  • Risk factors associated with sub-optimal outcomes and hematotoxicity following obecabtagene autoleucel (obe-cel) for relapsed/refractory B-cell acute lymphoblastic leukemia (R/R B-ALL)
    Meeting Abstract

    Sandhu, K. S.; Park, J. H.; Shaughnessy, P.; Logan, A. C.; Abedi, M.; Shah, B.; Bishop, M. R.; Deangelo, D. J.; Brugger, W.; Shang, J.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • CAR and ALL hematotox scores predict toxicity and outcomes among recipients of brexucabtagene autoleucel for R/R ALL in the real world outcomes collaborative of CAR-T in adult ALL (ROCCA) consortium
    Meeting Abstract

    Valtis, Y.; Lin, C. Y.; Nemirovsky, D.; Devlin, S.; Rejeski, K.; Shah, N. N.; Nair, M. S.; Jeyakumar, N.; Miller, K.; Zhang, A.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • PRC2-mediated apoptosis evasion is a therapeutic target of MDS/AML harboring inv(3)/t(3;3) and-7
    Meeting Abstract

    Kunimoto, H.; Honma, D.; Tsutsumi, S.; Sakuma, T.; Ohashi, T.; Teranaka, H.; Ikeda, J.; Toya, T.; Harada, Y.; Doki, N.; more...
    Cancer Science (2025)

    Fulltext@MSK | Save
  • Efficacy and safety of nano-CSF-1R inhibitor targeting microenvironment of sarcomas
    Meeting Abstract

    Fujiwara, T.; Yakoub, M.; Chandler, A.; Kondo, A.; Nakata, E.; Kunisada, T.; Ozaki, T.; Ouerfelli, O.; Purdue, E.; Healey, J.
    Cancer Science (2025)

    Fulltext@MSK | Save
  • Personalized RNA Vaccines for Pancreatic Cancer
    Meeting Abstract

    Balachandran, V. P.
    Cancer Science (2025)

    Fulltext@MSK | Save
  • Enhancing the persistence and anti-tumor efficacy of CAR-T and CAR-NK cells through genetic disruption of death receptors
    Meeting Abstract

    Cohen, T. D.; Yi, F.; Zumbo, P.; Etilib, R.; Arkin, H.; Gormally, M.; Hackett, C. S.; Kropp, K.; Etxeberria, I.; Chandran, S. S.; more...
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • Correlative science from a phase I study of intravesical Fc-optimized anti-CD40 agonist antibody 2141-V11 for non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus calmette-guerin (BCG)
    Meeting Abstract

    Bochner, B. H.; Alam, S. M.; Blanchard, L.; Yao, N.; Angulo-Lozano, J.; Wong, J.; Knorr, D.; Whiting, K.; Seshan, V.; Donahue, T.; more...
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save
  • Clinical and genomic characterization of a single-center cohort of renal cell carcinoma patients with KRAS mutation
    Meeting Abstract

    Sanmiguel, A. L.; Hakimi, A. A.; Khandwala, Y.; Calderon, L. P.; Dawidek, M.; Chen, Y. B.; Russo, P.; Coleman, J.; Carlo, M.
    Urologic Oncology: Seminars and Original Investigations (2025)

    Fulltext@MSK | Save